Comparison of sexual function in infertile women with polycystic ovary syndrome and endometriosis: A cross-sectional study


Background: Infertility is one of the issues affecting sexual function (SF). Infertility is also one of the complications of polycystic ovary syndrome (PCOS) and endometriosis.

Objective: This research seeks to assess and compare SF and the prevalence of sexual dysfunction in infertile women with PCOS and endometriosis.

Materials and Methods: A cross-sectional study was carried out with a sample of 630 (210 infertile women with endometriosis, 210 infertile women with PCOS, and 210 healthy women of childbearing age as the control group). SF was assessed by the female sexual function index (FSFI). Descriptive statistics and inferential statistics were used to analyze the data. The primary outcome measured was FSFI score. Secondary outcome was hospital anxiety and depression scale score.

Results: The results showed that the mean score of the total FSFI in the 2 groups of PCOS and endometriosis was lower than the control group (p < 0.001). In addition, women with higher education (university education) had a higher total FSFI.

Conclusion: Sexual dysfunction rates are high in infertile women with endometriosis and PCOS. Infertility service providers in infertility centers need to pay attention to this issue.

Key words: Polycystic ovarian syndrome, Endometriosis, Infertility, Sexual dysfunction.

[1] Casu G, Ulivi G, Zaia V, Fernandes Martins MDC, Parente Barbosa C, Gremigni P. Spirituality, infertilityrelated stress, and quality of life in Brazilian infertile couples: Analysis using the actor-partner interdependence mediation model. Res Nurs Health 2018; 41: 156–165.

[2] Alihocagil Emec Z, Apay SE, Ozorhan EY. Determination and comparison of sexual dysfunctions of women with and without Infertility problems. Sexual Disabil 2017; 35: 59–72.

[3] Massarotti C, Gentile G, Ferreccio C, Scaruffi P, Remorgida V, Anserini P. Impact of infertility and infertility treatments on quality of life and levels of anxiety and depression in women undergoing in vitro fertilization. Gynecol Endocrinol 2019; 35: 485–489.

[4] Turchi P. Prevalence, definition, and classification of infertility, in clinical management of male infertility. In: Cavallini G, Beretta G. Clinical management of male infertility. UK: Springer Cham; 2015: 5–11.

[5] Bakhtiari A, Basirat Z, Nasiri-Amiri F. Sexual dysfunction in women undergoing fertility treatment in Iran: Prevalence and associated risk factors. J Reprod Infertil 2016; 17: 26–33.

[6] Mirblouk F, Asgharnia M, Solimani R, Fakor F, Salamat F, Mansoori S. Comparison of sexual dysfunction in women with infertility and without infertility referred to Al-Zahra hospital in 2013-2014. Int J Reprod BioMed 2016; 14: 117–124.

[7] Gupta S, Harlev A, Agarwal A. Endometriosis and PCOS: Two major pathologies linked to oxidative stress in women. In: Yves M. Oxidative stress and womens health. France: Eska; 2015.

[8] Shafti V, Shahbazi S. Comparing sexual function and quality of life in polycystic ovary syndrome and healthy women. J Family Reprod Health 2016; 10: 92–98.

[9] Di Donato N, Montanari G, Benfenati A, Monti G, Leonardi D, Bertoldo V, et al. Sexual function in women undergoing surgery for deep infiltrating endometriosis: A comparison with healthy women. J Fam Plann Reprod Health Care 2015; 41: 278–283.

[10] Di Donato N, Seracchioli R. Endometriosis and sexuality. In: Costantini E, Villari D, Filocamo MT. Female sexual function and dysfunction. UK: Springer Cham; 2017: 63–77.

[11] Bisht Sh, Faiq M, Tolahunase M, Dada R. Oxidative stress and male infertility. Nat Rev Urol 2017; 14: 470–

[12] Maiorino MI, Bellastella G, Esposito K. Diabetes and sexual dysfunction: Current perspectives. Diabetes Metab Syndr Obes 2014; 7: 95–105.

[13] Agarwal A, Virk G, Ong C, du Plessis SS. Effect of oxidative stress on male reproduction. World J Mens Health 2014; 32: 1–17.

[14] Ma R, Yu J, Xu D, Yang L, Lin X, Zhao F, et al. Effect of felodipine with irbesartan or metoprolol on sexual function and oxidative stress in women with essential hypertension. J Hypertens 2012; 30: 210–216.

[15] Dashti S, Abdul Latiff L, Abdul Hamid H, Mohamad Saini S, Shah Abu Bakar A, Binti Sabri NAI, et al. Prevalence of polycystic ovary syndrome among Malaysian female university staff. J Midwif Reprod Health 2019; 7: 1560– 1568.

[16] Kajiyama H, Suzuki S, Yoshihara M, Tamauchi S, Yoshikawa N, Niimi K, et al. Endometriosis and cancer. Free Radic Biol Med 2019; 133: 186–192.

[17] Lauritsen MP, Bentzen JG, Pinborg A, Loft A, Forma JL, Thuesen LL, et al. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone. Hum Reprod 2014; 29: 791–801.

[18] Stephenson KR, Toorabally N, Lyons L, Meston CM. Further validation of the female sexual function index: Specificity and associations with clinical interview data. J Sex Marital Ther 2016; 42: 448–461.

[19] Neijenhuijs KI, Hooghiemstra N, Holtmaat K, Aaronson NK, Groenvold M, Holzner B, et al. The female sexual function index (FSFI): A systematic review of measurement properties. J Sex Med 2019; 16: 640– 660.

[20] Kor E, Saadat Mostafavi SR, Ahmadian Mazhin Z, Dadkhah A, Kor A, Habibi Arvanagh Sh, et al. Relationship between the severity of endometriosis symptoms (dyspareunia, dysmenorrhea and chronic pelvic pain) and the spread of the disease on ultrasound. BMC Res Notes 2020; 13: 546.

[21] Amini P, Maroufizadeh S, Omani Samani R. Evaluating the factor structure, item analyses, and internal consistency of hospital anxiety and depression scale in Iranian infertile patients. Int J Reprod BioMed 2017; 15: 287–296.

[22] Mabrouk M, Montanari G, Di Donato N, Del Forno S, Frascà C, Geraci E, et al. What is the impact on sexual function of laparoscopic treatment and subsequent combined oral contraceptive therapy in women with deep infiltrating endometriosis? J Sex Med 2012; 9: 770–778.

[23] Witchel SF, Oberfield ShE, Peña AS. Polycystic ovary syndrome: Pathophysiology, presentation, and treatment with emphasis on adolescent girls. J Endocr Soc 2019; 3: 1545–1573.

[24] Thannickal A, Brutocao C, Alsawas M, Morrow A, Zaiem F, Murad MH, et al. Eating, sleeping and sexual function disorders in women with polycystic ovary syndrome (PCOS): A systematic review and meta-analysis. Clin Endocrinol (Oxf) 2020; 92: 338–349.

[25] Cooney LG, Dokras A. Depression and anxiety in polycystic ovary syndrome: Etiology and treatment. Curr Psychiatry Rep 2017; 19: 83.

[26] Dashti S, Latiff LA, Abdul Hamid H, Sani SM, AkhtariZavare M, Shah Abu Bakar A, et al. Sexual dysfunction in patients with polycystic ovary syndrome in Malaysia. Asian Pac J Cancer Prev 2016; 17: 3747–3751.

[27] Inal ZO, Inal HA, Gorkem U. Sexual function and depressive symptoms in primary infertile women with vitamin D deficiency undergoing IVF treatment. Taiwan J Obstet Gynecol 2020; 59: 91–98.

[28] Murgel ACF, Simões RS, Maciel GAR, Soares-Jr JM, Baracat EC. Sexual dysfunction in women with polycystic ovary syndrome: Systematic review and meta-analysis. J Sex Med 2019; 16: 542–550.

[29] Pastoor H, Timman R, de Klerk C, Bramer WM, Laan ET, Se Laven J. Sexual function in women with polycystic ovary syndrome: A systematic review and meta-analysis. Reprod Biomed Online 2018; 37: 750– 760.

[30] Hashemi S, Ramezani Tehrani F, Noroozzadeh M, Rostami Dovom M, Azizi F. Infertility, the most adverse
outcome among sexual function outcome affecting of iranian women with polycystic ovarian syndrome. Iran J Endocrinol Metab 2014; 16: 197–204.

[31] Koneru A, Priyanka S. Polycystic ovary syndrome (PCOS) and sexual dysfunctions. J Psychosexual Health 2019; 1: 154–158.